Black Cohosh as Alternative Therapy for Treating Menopause-Related Anxiety
Completed · Phase 4 · Has a placebo group
Conditions studied: Generalized Anxiety Disorder, Menopause
In brief
This study will determine the effectiveness of the herb black cohosh for treating menopause-related anxiety symptoms in women. Study hypotheses: 1) Black cohosh will have a superior anti-anxiety effect compared to placebo. 2) Black cohosh will have a comparable safety profile to that of placebo.
Key facts
- Study ID
- NCT00120458
- Run by
- University of Pennsylvania
- People needed
- 50
- Starts
- 2005-07-01
- Expected to finish
- 2008-12-01
- Last updated by the study team
- 2010-03-02
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Currently experiencing menopause or postmenopausal
- Have symptoms of menopause-related anxiety
You may not qualify if…
- Any form of generalized anxiety disorder (GAD) unrelated to menopause
- Onset of GAD at least 3 years prior to menopause or at least 5 years after menstruation has stopped
- Alcohol or drug dependence within 3 months prior to study entry
- Allergy to black cohosh
- History of hormone replacement therapy
- Current use of vaginal estrogen cream or phytoestrogens
- Current use of tranquilizers, antidepressants, or antianxiety therapies
- Abnormal uterine bleeding
- History of estrogen-dependent cancer
- History of endometrial hyperplasia (abnormal increase in cells) or endometrial cancer
- Rapidly growing uterine fibroids
- Abnormal finding upon gynecological examination that would interfere with the study
- Abnormal breast examination or mammogram
- Any unstable medical condition
Where it is running
- Depression Research Unit, University of Pennsylvania School of Medicine — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.